Pembrolizumab vs Trimethaphan Camsylate
Pembrolizumab vs Trimethaphan Camsylate: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Trimethaphan Camsylate.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days.
Chemical Properties
Type: Pembrolizumab — Antibody; Trimethaphan Camsylate — Small molecule.